Trials / Unknown
UnknownNCT02390986
An Extension Study of LON002 in Patients With Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- LondonPharma Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical trial is to evaluate the long term safety and efficacy of LON002.
Detailed description
This is an extension study of LON002 in patients with cancer, who have completed other London Pharma sponsored LON002 studies (parent study). It provides the opportunity for patients to continue receiving treatment for as long as the patient continues to derive a clinical benefit. Long term safety and efficacy will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LON002 | Extension study to provide continuing access to LON002 medication. |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2015-03-18
- Last updated
- 2015-03-18
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02390986. Inclusion in this directory is not an endorsement.